← All candidates
47 insider filings on record.
47 filings on record.
LYELLyell Immunopharma, Inc.
NasdaqGS · Healthcare · $264.04M
$10.77
-1.24% today
47 insider filings on record.
None of them an open-market buy in the last year.
Price · 1Y · daily● 22 sells
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
Reverse-split 1×. When a company does a reverse split, the chart rewrites its old prices to look far bigger than they really were — so the high early prices here aren't what LYEL ever actually traded at. The drop is real, but those huge old numbers aren't.
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$264.04M
Float
12.1M
50% public
Short % float
Pro
Price / profit
—
not yet profitable
Price / future profit
—
Price / sales
9779.4
Institutional stakes
▸ a holder crossing 5% files Schedule 13D if they intend to act on the company, 13G if they certify they will not · /A amends an earlier filing
1 filingnewest first
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
42 more transactions on Pro →Context
Wall St
$37.17 avg target
+244.9% vs today · 6 analysts · consensus Buy
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
3 of 4 quarters beat
Q1 '26−$1.10 act+$1.26
Q4 '25−$7.68 act−$5.45
Q3 '25−$2.13 act+$0.51
Q2 '25−$2.89 act+$0.69
Coverage
Is Lyell Immunopharma (NASDAQ:LYEL) In A Good Position To Deliver On Growth Plans?Simply Wall St. · 06-09Lyell Immunopharma's Cancer Therapy Shows Improved Safety in Phase 1 StudyMT Newswires · 06-08Lyell Immunopharma (LYEL) Loses 39.7% in 4 Weeks, Here's Why a Trend Reversal May be Around the CornerZacks · 06-04Lyell Immunopharma Targets 2027 FDA Filing as CAR-T Pipeline AdvancesMarketBeat · 05-27
The file stays open
47 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice